Product Description |
Recombinant Human GPRC5D Protein-VLP is expressed from HEK293.It contains Met1-Val345. |
Product Background |
Chimeric antigen receptor (CAR) T cells, a type of cell-based immunotherapy, have shown some promising results in multiple myeloma, a bone marrow cancer. The orphan G protein–coupled receptor, class C group 5 member D (GPRC5D), normally expressed only in the hair follicle, using quantitative immunofluorescence, we determined that GPRC5D protein is expressed on CD138 MM cells from primary marrow samples with a distribution that was similar to, but independent of, BCMA. |
Product Category |
Recombinant Protein |
Target |
GPRC5D |
Synonyms |
GPRC5D; MGC129713; MGC129714; orphan G-protein coupled receptor |
Accession |
|
Species |
Human |
Biotinylated |
no |
Amino Acid Range |
Met1-Val345 |
Molecular Weight |
The target protein has a predicted MW of 39.6 kDa. |
Activity |
Immobilized Human GPRC5D VLP at 5 ug/ml (100 ul/Well) on the plate. Dose response curve for Anti-GPRC5D Antibody, hFc Tag with the EC50 of 3.8 ng/ml determined by ELISA. See testing image for detail. |
Express System |
HEK293 |
Purity |
>95% as determined by HPLC |
Endotoxin |
Less than 1 EU per ug by the LAL method. |
Form |
Liquid |
Shipping |
Shipped with dry ice. |
Formulation |
Supplied as 0.22 um filtered solution in PBS, 300 mM L-Arginine (pH 7.4). |
Stability And Storage |
Valid for 12 months from date of receipt when stored at -80°C.； Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
|
|
Immobilized Human GPRC5D VLP at 5 ug/ml (100 ul/Well) on the plate. Dose response curve for Anti-GPRC5D Antibody, hFc Tag with the EC50 of 3.8 ng/ml determined by ELISA. |
|
|
The purity of Human GPRC5D VLP is greater than 95% as determined by SEC-HPLC. |
Product Resources
Related Products
Have more questions?
Check out our Frequently Asked Questions page for more details about product specifications, ordering, and shipments.
Contact Us
Recently viewed
